BRCA1 and BRCA2 gene mutations are typically found in 25–30% of the breast cancer families subjected to genetic testing (Giannini et al., 2006; Economopoulou, Dimitriadis & Psyrri, 2015). This evidence concerns the gene BRCA2 and breast carcinoma.